NEW YORK (GenomeWeb) – The Centers for Medicare & Medicaid Services has agreed to "exercise enforcement discretion" for 60 days, giving laboratories some more time to report private payor pricing data required under the Protecting Access to Medicare Act (PAMA). 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.